HKEX:1276

Jiangsu Hengrui Pharmaceuticals . Stock Forecast

etoro logo Buy 1276
*Your capital is at risk
HK$57.60
-0.350 (-0.604%)
At Close: Aug 11, 2026

Should you buy 1276.HK stock?

Last updated:

Based on market data through , StockInvest.us rates Jiangsu Hengrui Pharmaceuticals Co.,ltd (1276.HK) as Hold/Accumulate with a technical score of -0.88 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Down 1.54%
  • 3-month trend forecast Down 5.94%
  • Hold/Accumulate -0.88
AI Analysis AI Analysis of 1276.HK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add 1276 to Watchlist?
Some Reasons Why To Add 1276:
  • High gross margin of 86.2%
  • Healthy interest coverage ratio of 2,315.2x
  • Lower volatility than the market (beta 0.12)
PDF

Red day on Tuesday for Jiangsu Hengrui Pharmaceuticals Co.,ltd
(Market data through Aug 11, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Aug 07, 2026 Loss -1.54%

The Jiangsu Hengrui Pharmaceuticals Co.,ltd stock price fell by -0.604% on the last day (Tuesday, 11th Aug 2026) from HK$57.95 to HK$57.60. During the last trading day the stock fluctuated 3.41% from a day low at HK$57.25 to a day high of HK$59.20. The price has fallen in 6 of the last 10 days. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 3 million shares were bought and sold for approximately HK$174.74 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.94% during the next 3 months and, with a 90% probability hold a price between HK$46.58 and HK$61.26 at the end of this 3-month period.

1276.HK Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 9.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Jiangsu Hengrui Pharmaceuticals Co.,ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at HK$57.72. On a fall, the stock will find some support from the short-term average at HK$57.59. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Jiangsu Hengrui Pharmaceuticals Co.,ltd stock

Jiangsu Hengrui Pharmaceuticals Co.,ltd finds support from accumulated volume at HK$56.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved HK$1.95 between high and low, or 3.41%. For the last week the stock has had daily average volatility of 4.51%.

Our recommended stop-loss: HK$55.30 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 44 days ago.)

Trading Expectations (1276.HK) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Jiangsu Hengrui Pharmaceuticals Co.,ltd to open at HK$58.02, and during the day (based on 14 day Average True Range), to move between HK$56.35 and HK$58.85, which gives a possible trading interval of +/-HK$2.51 (+/-4.45%) up or down from last closing price. If Jiangsu Hengrui Pharmaceuticals Co.,ltd takes out the full calculated possible swing range there will be an estimated 4.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$57.95 (0.61%) than the support at HK$56.60 (1.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Jiangsu Hengrui Pharmaceuticals Co.,ltd will release earnings on Monday, August 17, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.439. We will update the financials statements for Jiangsu Hengrui Pharmaceuticals Co.,ltd, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 2.34% in the first trading day after earnings release.

Is Jiangsu Hengrui Pharmaceuticals Co.,ltd stock A Buy?

Jiangsu Hengrui Pharmaceuticals Co.,ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.880 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - HK$58.02 ( 0.723%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

1276.HK Performance

Trading levels for 1276.HK

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 59.97 4.11%
R2 59.22 2.82%
R1 58.76 2.02%
Price 57.60
S1 57.27 -0.570%
S2 56.81 -1.37%
S3 56.07 -2.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 69.25 20.23%
R2 58.50 1.56%
R1 57.95 0.608%
Price 57.60
S1 56.60 -1.74%
S2 54.70 -5.03%
S3 53.35 -7.38%

1276 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 29, 2026 Apr 29, 2026 May 27, 2026 HK$0.228 0.380%

FAQ

What is the symbol for Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock and on which exchange is it traded?
The symbol for Jiangsu Hengrui Pharmaceuticals Co.,ltd is 1276.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock?
Based on market data through Aug 11, 2026, StockInvest.us rates Jiangsu Hengrui Pharmaceuticals Co.,ltd (1276.HK) as Hold/Accumulate with a technical score of -0.88 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 07, 2026, the price has fallen 1.54%. The current 3-month trend forecast projects a fall of 5.94%.

How to buy Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock?
Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock.

What's the current price of Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock?
As of the end of day on the Aug 11, 2026, the price of an Jiangsu Hengrui Pharmaceuticals Co.,ltd (1276.HK) share was HK$57.60.

What is the 52-week high and low for Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock?
The 52-week high for Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock is HK$95.20 and the 52-week low is HK$51.30.

What is the market capitalization of Jiangsu Hengrui Pharmaceuticals Co.,ltd Stock?
As of the Aug 11, 2026, the market capitalization of Jiangsu Hengrui Pharmaceuticals Co.,ltd is 382.303B.

When is the next earnings date for Jiangsu Hengrui Pharmaceuticals Co.,ltd?
The upcoming earnings date for Jiangsu Hengrui Pharmaceuticals Co.,ltd is Aug 17, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE